ANVS
Price
$1.49
Change
-$0.01 (-0.67%)
Updated
Apr 1 closing price
Capitalization
29.23M
36 days until earnings call
MDGL
Price
$323.98
Change
-$7.25 (-2.19%)
Updated
Apr 1 closing price
Capitalization
7.15B
41 days until earnings call
Ad is loading...

ANVS vs MDGL

Header iconANVS vs MDGL Comparison
Open Charts ANVS vs MDGLBanner chart's image
Annovis Bio
Price$1.49
Change-$0.01 (-0.67%)
Volume$215.36K
Capitalization29.23M
Madrigal Pharmaceuticals
Price$323.98
Change-$7.25 (-2.19%)
Volume$331.09K
Capitalization7.15B
ANVS vs MDGL Comparison Chart
Loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANVS vs. MDGL commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a Buy and MDGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (ANVS: $1.49 vs. MDGL: $323.98)
Brand notoriety: ANVS and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 43% vs. MDGL: 89%
Market capitalization -- ANVS: $29.23M vs. MDGL: $7.15B
ANVS [@Biotechnology] is valued at $29.23M. MDGL’s [@Biotechnology] market capitalization is $7.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 0 FA rating(s) are green whileMDGL’s FA Score has 1 green FA rating(s).

  • ANVS’s FA Score: 0 green, 5 red.
  • MDGL’s FA Score: 1 green, 4 red.
According to our system of comparison, MDGL is a better buy in the long-term than ANVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 5 TA indicator(s) are bullish while MDGL’s TA Score has 3 bullish TA indicator(s).

  • ANVS’s TA Score: 5 bullish, 3 bearish.
  • MDGL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ANVS is a better buy in the short-term than MDGL.

Price Growth

ANVS (@Biotechnology) experienced а -24.37% price change this week, while MDGL (@Biotechnology) price change was -5.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.02%. For the same industry, the average monthly price growth was -13.19%, and the average quarterly price growth was -12.16%.

Reported Earning Dates

ANVS is expected to report earnings on May 08, 2025.

MDGL is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-9.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($7.15B) has a higher market cap than ANVS($29.2M). MDGL YTD gains are higher at: 4.994 vs. ANVS (-70.378). ANVS has higher annual earnings (EBITDA): -30.4M vs. MDGL (-450.12M). MDGL has more cash in the bank: 926M vs. ANVS (12.6M). MDGL has higher revenues than ANVS: MDGL (180M) vs ANVS (0).
ANVSMDGLANVS / MDGL
Capitalization29.2M7.15B0%
EBITDA-30.4M-450.12M7%
Gain YTD-70.3784.994-1,409%
P/E RatioN/AN/A-
Revenue0180M-
Total Cash12.6M926M1%
Total DebtN/A120M-
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
74
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
PROFIT vs RISK RATING
1..100
28
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANVSMDGL
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
MACD
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
81%
Advances
ODDS (%)
Bullish Trend 9 days ago
83%
Bullish Trend 10 days ago
78%
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 8 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 7 days ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 1 day ago
63%
View a ticker or compare two or three
Ad is loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PUBM9.290.15
+1.64%
PubMatic
KR68.140.45
+0.66%
Kroger Co (The)
FNLC24.870.15
+0.61%
First Bancorp
MRM0.37N/A
+0.46%
MEDIROM Healthcare Technologies
ESGR332.06-0.32
-0.10%
Enstar Group Limited

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
-0.67%
ADXN - ANVS
40%
Loosely correlated
-3.27%
MDGL - ANVS
36%
Loosely correlated
-2.19%
EWTX - ANVS
33%
Poorly correlated
-8.50%
VTYX - ANVS
32%
Poorly correlated
-6.96%
AXON - ANVS
31%
Poorly correlated
+2.90%
More

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with KANT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then KANT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
-2.19%
KANT - MDGL
62%
Loosely correlated
-17.46%
ALXO - MDGL
56%
Loosely correlated
-1.77%
ZNTL - MDGL
51%
Loosely correlated
-12.58%
CGEM - MDGL
50%
Loosely correlated
-0.92%
TSVT - MDGL
50%
Loosely correlated
+0.20%
More